Skip to content

Clinical trials

Recruiting Phase 1 Stomach Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 1 Status: Recruiting Clear all

73 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20203
20217
20225
202310
202412
202523
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting73

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chongqing Precision Biotech Co., Ltd4
Seagen, a wholly owned subsidiary of Pfizer3
AbbVie2
Eli Lilly and Company2
Fox Chase Cancer Center2
National Cancer Institute (NCI)2
Sichuan Baili Pharmaceutical Co., Ltd.2
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)1
ArriVent BioPharma, Inc.1
Aurigene Discovery Technologies Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms73
Colorectal Neoplasms28
Esophageal Neoplasms25
Breast Neoplasms23
Carcinoma, Non-Small-Cell Lung22
Pancreatic Neoplasms19
Ovarian Neoplasms17
Neoplasm Metastasis15
Squamous Cell Carcinoma of Head and Neck13
Lung Neoplasms12

Trials

Showing 1 to 25 of 73. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.